Baylor Pharmaceutical Private Limited, a active private limited company, was established on 30 May 2019 in Rabale, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85110MH2019PTC326121. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.52 M.
It upholds a compliant status. Its leadership includes Panni Prashob (Director), Edadan Puthiyaveedu Suhesh (Director), Kandamkulngara Aneesh (Director). Past directors included Velandithai Thattari Aswani Aravind, Panni Prashob, Edadan Puthiyaveedu Suhesh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No-002, Chaudry Apt Sec-29C, Gothivali, Rabale, Maharashtra, 400701.
U85110MH2019PTC326121
326121
30 May 2019
₹4.00 M
₹3.52 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Baylor Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Panni Prashob | Director | 02 Mar 2021 | Current |
| Edadan Puthiyaveedu Suhesh | Director | 01 May 2021 | Current |
| Kandamkulngara Aneesh | Director | 22 May 2021 | Current |
| Anoop Murali | Director | 15 Dec 2023 | Current |
| Kalathilparambath Sujil | Director | 15 Dec 2023 | Current |
| Cheruliyil Mithun Das | Director | 15 Dec 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Baylor Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Baylor Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Baylor Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Baylor Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baylor Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sujesh Vallathana was appointed as a Additional Director was appointed as a Additional Director on 29 Aug 2025 & has been associated with this company since 3 months 26 days . was completed.
Baylor Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Baylor Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Anoop Murali was appointed as a Director was appointed as a Director on 15 Dec 2023 & has been associated with this company since 2 years 9 days . was recorded as a recent event.
Kalathilparambath Sujil was appointed as a Director was appointed as a Director on 15 Dec 2023 & has been associated with this company since 2 years 9 days . was recorded as a recent event.
Progress on Cheruliyil Mithun Das was appointed as a Director was appointed as a Director on 15 Dec 2023 & has been associated with this company since 2 years 9 days . was documented.
The CIN of Baylor Pharmaceutical Private Limited is U85110MH2019PTC326121.
Baylor Pharmaceutical Private Limited is headquartered at Shop No-002, Chaudry Apt Sec-29C, Gothivali, Rabale, Maharashtra, 400701.
Baylor Pharmaceutical Private Limited was incorporated on 30 May 2019.
The current directors of Baylor Pharmaceutical Private Limited are
The primary industry of Baylor Pharmaceutical Private Limited is Pharma.
Baylor Pharmaceutical Private Limited is unlisted.
The authorized capital of Baylor Pharmaceutical Private Limited is ₹4.00 M, and the paid-up capital is ₹3.52 M.
The compliance status of Baylor Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX